Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1

NCT01226771 is registered in ClinicalTrials.gov with Göteborg University as lead sponsor.

NCT NCT01226771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1
Lead sponsor
Göteborg University
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
September 30, 2014
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c